C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2004
12/09/2004	WO2004106524A1 Protease, dna coding for the protease and process for producing the protease
12/09/2004	WO2004106512A1 Method of enhancing pathogen-resistance of plant
12/09/2004	WO2004106502A1 Mesenchymal stem cell
12/09/2004	WO2004106501A1 Method of freezing and preserving monocytic established cell line and culture medium for use in the method
12/09/2004	WO2004106500A1 Method for increasing the yield of proliferating primary keratinocytes
12/09/2004	WO2004106499A1 Method for expanding cells
12/09/2004	WO2004105477A2 Method for cloning in the rat by nuclear transfer
12/09/2004	WO2004050848A3 Methods for antigen masking of red blood cells resulting in reduced hemolysis
12/09/2004	WO2004043344A3 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same
12/09/2004	WO2004038003A3 Human polypeptides encoded by polynucleotides and methods of their use
12/09/2004	WO2004017728A3 Methods
12/09/2004	WO2004012503A3 Compositions comprising muscle progenitor cells and uses thereof
12/09/2004	WO2003106623A3 Early noninvasive prenatal test for aneuploidies and heritable conditions
12/09/2004	WO2003100070A3 The frog prince, a transposon vector for gene transfer in vertebrates
12/09/2004	WO2003080808A3 Novel compositions and methods in cancer
12/09/2004	WO2003062382A3 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals
12/09/2004	WO2003062262A3 Modulation of heat-shock-protein-based immunotherapies
12/09/2004	WO2003057835A3 Pak5-related compositions and methods
12/09/2004	US20040250315 Sd1 gene involved in plants semidwarfing and utilization thereof
12/09/2004	US20040250301 Transgenic animals
12/09/2004	US20040249448 Device for active phase cell or tissue sampling and uses thereof
12/09/2004	US20040249178 Biological conjugates used for drug delivery; side effect reduction
12/09/2004	US20040249143 Hagfish cathelin-associated antimicrobial peptides and genes
12/09/2004	US20040249139 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss
12/09/2004	US20040249134 Factor viii c2 domain variants
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249128 Disease detection polypeptides diagnosis, treatment, and prevention of cell proliferative, autoimmune/inflammatory, developmental and neurological disorders
12/09/2004	US20040249126 Chimeric antigen-specific t cell-activating polypeptides
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040248984 Use of $g(b)-adrenoceptor agonists for the treatment of neurodegenerative diseases
12/09/2004	US20040248871 Prevent cell differentiation
12/09/2004	US20040248837 Methods of treating pulmonary fibrotic disorders
12/09/2004	US20040248829 Gene expression in embryonic pancreas cells, adipocytes; prevent metabolic disorders; antidiabetic agents; obesity; eating disorders; neurodegenerative disorders
12/09/2004	US20040248798 Contraceptive methods and compositions related to proteasomal interference
12/09/2004	US20040248791 Insect g protein-coupled receptor genes and uses thereof
12/09/2004	US20040248786 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
12/09/2004	US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators
12/09/2004	US20040248298 Methods for purification of bacterial cells and components
12/09/2004	US20040248296 HIV therapeutic
12/09/2004	US20040248295 Culturing cell populations which are weakly positive or negative for hematopoietic stem cells lineage marker gene expression in mixture comprising colony stimulating factors and isolating amplified hematopoietic cells
12/09/2004	US20040248294 use of ceramide 7 and/or 5.5 in a culture medium of reconstructed epidermis/skin or topically on reconstructed epidermis/skin; tissue engineering, regeneration and repair
12/09/2004	US20040248293 Microinjection of cryoprotectants for preservation of cells
12/09/2004	US20040248292 Keratinocytes obtained from embryonic stem cells of mammals
12/09/2004	US20040248291 Propagating cells/tissue in nutrient broth using magnetic fields and magnetic particles coated with material which enhances cell adhesion; tissue engineering; drug safety screening
12/09/2004	US20040248290 Bioreactor comprising biodegradable gels composed of low-molecular-weight nutrients for high density propagation/culturing of cell tissues
12/09/2004	US20040248288 Compositions and methods for efficient aav vector production
12/09/2004	US20040248262 Nucleotide sequences coding lysosomal protein for use treatment of brain and muscular disorders
12/09/2004	US20040248257 Spleen expressed cell surface protein (SPLEX) for use in treatment and prevention autoimmunity, cancer, transplant rejection and inflammation
12/09/2004	US20040248256 Secreted proteins and polynucleotides encoding them
12/09/2004	US20040248254 ACPL DNA and polypeptides
12/09/2004	US20040248252 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders
12/09/2004	US20040248251 Receptors and membrane associated proteins
12/09/2004	US20040248249 Protein for use in treatment, prevention and diagnosis of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological, and developmental disorders
12/09/2004	US20040248243 Lipid metabolizing polypeptide for use in identifying modulators for treatment and prevention of cancer, nervous system, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders
12/09/2004	US20040248240 Nucleotide sequences coding membrane protein for use in identifying modulator for treatment of pain management, epilepsy, stroke, ischemia and heart disease
12/09/2004	US20040248238 Method for increasing the solubility, expression rate and the acitivity of proteins during recombinant production
12/09/2004	US20040248207 Sodium channel regulators and modulators
12/09/2004	US20040248180 Nucleotide sequences coding modified chromgenic and/or fluorescent protein for use as diagnostic indicators in genetic engineering
12/09/2004	US20040248178 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders
12/09/2004	US20040248173 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder
12/09/2004	US20040248155 Novel oncogene, recombinant protein derived therefrom, and uses thereof
12/09/2004	US20040248149 Nucleotide sequences coding G-protein coupled receptor (T2R) for use in identifying modulators which control bitterness; food processing and pharmocological design
12/09/2004	US20040248143 Generating novel polypeptides via non-stochastic polynucleotide site-saturation mutagenesis; protein bioengineering
12/09/2004	US20040248141 Transgenic cell comprising nucleotide sequences which form triplex structures for use in diagnosis, prevention and treatment of skin, pigmentation and cell proliferative disorders
12/09/2004	US20040248133 Method for determining cell cycle position
12/09/2004	US20040248129 Neural polypeptide for use as tool in identifying modulators for controlling body weight; treating obesity
12/09/2004	US20040248124 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
12/09/2004	US20040248115 Nucleotide sequence probes for detecting beer-spoilage lactic acid bacteria; food processing and alcoholic beverages
12/09/2004	US20040248083 Viral plasmid comprising heterologous or synthetic dimerisation sequences which promotes dimer formation of plasmid transcripts and prevents recombination between plasmid transcripts and another retrovirus present in genome; gene transfer tool; bioreactor
12/09/2004	US20040248077 Multicompartment system which utilizes binding/adhesion mimetics for collecting a subpopulation of cells from a digested organ or other biological material
12/09/2004	US20040247691 wound healing and tissue forming compositions with suitable cells affixed to prosthetic devices; microbeads are prepared by coagulation and emulsification of fibrinogen, thrombin and factor XIII without gluteraldehyde as a crosslinking agent
12/09/2004	US20040247661 injectable liposomal composition for delivery of large amounts of water-soluble substance comprises a plurality of liposomal vesicles having a high weight ratio of lipid to encapsulated water-soluble substance which is distributed over the liposomal vesicles; high efficiency of encapsulation
12/09/2004	US20040247616 Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof
12/09/2004	US20040247615 A nucleic acid comprising a nucleotide sequence encoding a Met-NS3-NS4A-NS4B-NS5A-NS5B polypeptide containing an inactive NS5B RNA-dependent RNA polymerase region; adenovector or DNA plasmid vaccine; cultured cells expressing the nucleic acid; vaccination
12/09/2004	US20040247609 Administering a non-specific immunopotentiator before administering an antigen protein ; particularly administering a cancer antigen protein, WT1, or a peptide derived from the WT1 protein in combination with a bacterium-derived component or IFN-alpha
12/09/2004	US20040247600 Agent that specifically binds to human MTAP protein in an embedded biological sample, especially a polyclonal antibody or a monoclonal antibody produced by hybridoma cell line ATCC Accession No. PTA-5001
12/09/2004	US20040247599 Modulators of the P2Y10 receptor useful in altering T lymphocyte function
12/09/2004	US20040247595 Related to the potassium channel subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity
12/09/2004	US20040247579 Mixed chimerism and tolerance
12/09/2004	US20040247575 Especially cells containing an exogenous nucleic acid encoding VEGF, fibroblast growth factor-4, a natiuretic peptide, prostacyclin synthase, nitric oxide synthase, angiostatin, endostatin, erythropoietin, granulocyte/macrophage colony stimulating factor, an integrin, or an interleukin
12/09/2004	US20040247574 Improving stem cell homing to bone marrow by contacting them for a period insufficient for cell division to occur with a CD26 peptidase inhibitor before administering them to a patent in need
12/09/2004	US20040247573 Living stromal tissue including mesenchymal cells of hair follicle (especially scalp or beard follicle) cultured in a three-dimensional framework and connective tissue proteins secreted from the cells; and a transitional covering connected to the stromal tissue.
12/09/2004	US20040247572 Hair follicle-reconstitution system and animal carrying the same
12/09/2004	US20040247571 Neural cells expressing tyrosine hydroxylase
12/09/2004	US20040247564 Treating a tissue disorder involving a loss and/or apoptosis of cells by administering an agent that induces phosphorylation and/or activation of protein kinase B to cause proliferation; particularly administering a human stromal-derived factor-1 and a G-CSF to cause proliferation of cardiomyocytes
12/09/2004	DE102004019852A1 New modified sarcosine oxidase, useful for assaying creatinine, e.g. for diagnosis of kidney disease, has improved stability under acidic conditions, also new DNA that encodes it
12/09/2004	CA2567823A1 In vitro platform for screening agents inducing islet cell neogenesis
12/09/2004	CA2527694A1 Fab library for the preparation of anti vegf and anti rabies virus fabs
12/09/2004	CA2526546A1 Methods for producing antibodies
12/09/2004	CA2525853A1 Method for cloning in the rat by nuclear transfer
12/08/2004	EP1484415A2 Method of alleviating pest infestation in plants
12/08/2004	EP1484412A2 Eukaryotic host cell line in which an endogenous gene has been activated, and uses thereof
12/08/2004	EP1484411A1 Stress resistant plant
12/08/2004	EP1484404A1 Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines
12/08/2004	EP1484403A1 Gene participating in the synthesis of brassinosteroid
12/08/2004	EP1484402A2 Antibody for use in therapy
12/08/2004	EP1484400A1 Sodium-independent transporter carrying acidic amino acid and its gene
12/08/2004	EP1484395A1 Transposon being functional in mammals
12/08/2004	EP1484392A1 Diacylglycerol acyltransferase genes, proteins and uses thereof
12/08/2004	EP1484390A1 Methods of preparing peripheral stem cells from leukocyte reduction filters

1 ... 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 ... 1827